Dupilumab efficacy in uncontrolled, moderate-to-serve allergic asthma in the phase 3 liberty asthma quest study
Autors principals: | , , , , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Publicat: |
Elsevier
2018
|
Autors principals: | , , , , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Publicat: |
Elsevier
2018
|